Axsome Therapeutics, Inc.
Nasdaq AXSM · New York, NY
Works in Musculoskeletal · Neurology · Psychiatry · Respiratory
Axsome Therapeutics, Inc. is a clinical trial sponsor based in New York, NY, listed as Nasdaq AXSM. It has 12 active clinical trials with 6,656 planned participants, in Musculoskeletal, Neurology, Psychiatry and Respiratory. Since 2021 it has completed 20 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq AXSM
Pipeline · 12 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
2 approved drug applications with a product on the market.
Questions about Axsome Therapeutics, Inc
Axsome Therapeutics, Inc is lead sponsor of 12 active clinical trials on ClinicalTrials.gov, with 6,656 planned participants, in Musculoskeletal, Neurology, Psychiatry, Respiratory. Since 2021 it has completed 20 trials and stopped 2 early.
Axsome Therapeutics, Inc is based in New York, NY and is listed as Nasdaq AXSM. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Axsome Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
Approve Suite is not affiliated with Axsome Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.